Cell Signaling Technology

PhosphoPlus® GSK-3 beta (Ser9) Antibody Duet

#8213 · $730

100
Citing papers
4.4k
Combined citations
Supplier page Find this product

Research areas

PI3K/AKT/mTOR signaling in cancer10Metabolism, Diabetes, and Cancer7Cancer-related gene regulation6Cancer-related molecular mechanisms research6Cancer, Hypoxia, and Metabolism5Cancer Mechanisms and Therapy5Epigenetics and DNA Methylation5MicroRNA in disease regulation5

Papers citing this product

1
Predicting clinical response to anticancer drugs using an ex vivo platform that captures tumour heterogeneity
Nature Communications·2015·307 cit.·DOI
2
p38/MKP-1–regulated AKT coordinates macrophage transitions and resolution of inflammation during tissue repair
The Journal of Cell Biology·2011·224 cit.·DOI
3
Activation of the Extracellular Signal-Regulated Kinase in the Amygdala Modulates Pain Perception
Journal of Neuroscience·2007·217 cit.·DOI
4
A Novel Signaling Network Essential for Regulating Pseudomonas aeruginosa Biofilm Development
PLoS Pathogens·2009·213 cit.·DOI
5
Modeling Initiation of Ewing Sarcoma in Human Neural Crest Cells
PLoS ONE·2011·175 cit.·DOI
6
Activation of p38 Has Opposing Effects on the Proliferation and Migration of Endothelial Cells
Journal of Biological Chemistry·2005·140 cit.·DOI
7
Activation of Metabotropic Glutamate Receptor 5 in the Amygdala Modulates Pain-Like Behavior
Journal of Neuroscience·2010·130 cit.·DOI
8
Structural basis for distinct roles of SMAD2 and SMAD3 in FOXH1 pioneer-directed TGF-β signaling
Genes & Development·2019·106 cit.·DOI
9
miR-491-5p-induced apoptosis in ovarian carcinoma depends on the direct inhibition of both BCL-XL and EGFR leading to BIM activation
Cell Death and Disease·2014·105 cit.·DOI
10
GRP78/BiP/HSPA5/Dna K is a universal therapeutic target for human disease
Journal of Cellular Physiology·2014·98 cit.·DOI
PhosphoPlus® GSK-3 beta (Ser9) Antibody Duet — Evidence — PubIndex